title: A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.
authors.affiliation: Department of Ophthalmology, Shanghai First People’s Hospital, Shanghai JiaoTong University, Shanghai, China.
authors.forename: Yi
authors.initials: Y
authors.lastname: Xu
authors.forename: Hui
authors.initials: H
authors.lastname: Zhao
authors.forename: Ying
authors.initials: Y
authors.lastname: Zheng
authors.forename: Qing
authors.initials: Q
authors.lastname: Gu
authors.forename: Jianxing
authors.initials: J
authors.lastname: Ma
authors.forename: Xun
authors.initials: X
authors.lastname: Xu
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002645:Chickens; D049033:Chorioallantoic Membrane / Q000098:blood supply / Q000187:drug effects; D042783:Endothelial Cells / Q000187:drug effects / Q000473:pathology; D017228:Hepatocyte Growth Factor / Q000008:administration & dosage / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008251:Macaca; D051379:Mice; D008810:Mice, Inbred C57BL; D010446:Peptide Fragments / Q000008:administration & dosage / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use*; D010455:Peptides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D055550:Protein Stability / Q000187:drug effects; D015861:Retinal Neovascularization / Q000188:drug therapy* / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A / Q000494:pharmacology
chemical_list: D020533:Angiogenesis Inhibitors; C581855:H-RN peptide; D010446:Peptide Fragments; D010455:Peptides; D042461:Vascular Endothelial Growth Factor A; D017228:Hepatocyte Growth Factor